A Review of the Potential Role of Methylnaltrexone in Opioid Bowel Dysfunction
Author:
- 1 November 2001
- journal article
- review article
- Published by Elsevier in The American Journal of Surgery
- Vol. 182 (5) , S19-S26
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Incidence, Prevalence, and Management of Opioid Bowel DysfunctionThe American Journal of Surgery, 2001
- Management of opioid-induced constipationCurrent Pain and Headache Reports, 2001
- Morphine, constipation and performance status in advanced cancer patientsPalliative Medicine, 1999
- Gut Motility and Transit Changes in Patients Receiving Long‐Term Methadone MaintenanceThe Journal of Clinical Pharmacology, 1998
- Side effects of morphine administration in cancer patientsCancer Nursing, 1998
- Assessment of nalmefene glucuronide as a selective gut opioid antagonistDrug and Alcohol Dependence, 1995
- Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinicJournal of Pain and Symptom Management, 1994
- Unrecognized constipation in patients with advanced cancer: A recipe for therapeutic disasterJournal of Pain and Symptom Management, 1992
- A long-term survey of morphine in cancer pain patientsJournal of Pain and Symptom Management, 1992
- Prevention of opioid side effectsJournal of Pain and Symptom Management, 1990